Valve is changing the frequency and content of Deadlock updates going forward, and this is good for the long term health of ...
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s ...
Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...
( MENAFN - IANS) New Delhi, Jan 8 (IANS) Kala-azar or visceral leishmaniasis -- a deadly neglected tropical disease -- can be ...
Investing.com -- Shares of Vir Biotechnology, Inc. (NASDAQ: VIR) surged 29% following the release of encouraging safety and efficacy data from ongoing dose escalation trials for its dual-masked T-cell ...
MBX Biosciences Inc. (NASDAQ:MBX) revealed results from its Phase 1 single ascending dose and multiple ascending dose trial ...
Fluoride exposure appears to slightly decrease IQ scores in children, a new federal meta-analysis has concluded -- but not at ...
Verywell Health on MSN16h
Is It Safe to Drink Coffee With Adderall?Combining Adderall with other CNS stimulants, such as caffeine, can increase the risk of side effects, including elevated ...
Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports.
The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...
A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names: canela-seca or canela-branca), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback